NYSE:PFE has formed double bottom and is now breaking nearer term downtrend. Has been in multi-year bearish trend. Forward P/E 10.19
Pfizer looks good at amp 27.8 .. it break the trend line expecting move up from here
LONG-TERM: Wedge, divergence, multi-year support. (not financial advice)
It seems like the price may have hit its bottom, as we're seeing two Key Reversals on the Monthly timeframe. This scenario could signal a Double Bottom, setting the stage for a high-probability trade setup with waiting for the price to break through the recent Lower High (LH) to confirm a change in trend. Shifting our focus to the Daily timeframe, there...
There is a possibility of further upside. That's a five-wave pattern rise
Aggressive CounterTrend Trade 10F - short impulse + biggest volume T1 + support level + biggest volume 2Sp Calculated affordable stop loss 1 to 2 R/R take profit before 1/2 of daily range Monthly Context - short impulse + 1/2 correction of 15 years long trend + historical volume + biggest volume of short trend
Pfizer (PFE) - signs of potential breakout 4-hour Pfizer is a large pharmaceutical company that develops and sells vaccines, including a vaccine for pneumonia. The company's stock is undervalued, and it is starting to show signs of a breakout. The stock is up over 10% in the past month, and it is trading above its 50-day moving average. Pfizer (PFE) Stock...
PFE is down about 55% from the start of 2022 (close to ATH), and at some very interesting technical level for over the past decade plus.
NYSE:PFE is certainly a dog but, it has put in a higher low and the moving averages are starting to turn up. I like to go bottom fishing occasionally. PFE is my new candidate. I have an alert set just above the current price where it may move above short-term resistance, around the thin blue line. If it triggers and I take this trade, I can put a stop close by...
Apologies for the sloppy chart as I need to share this without putting to much effort into making it look pretty. Look at the last earnings report EPS and tell me that big institutions aren't looking at this to buy... Its consolidated enough so far and this is bound to hit $34-$36 EZ PZ.
Hello. In searching of trade of Quarter and+ Thinking about PFE. Last Year Was be for this stock is in -43% and in 2022 Y was be -13%. This Year starting to searching a levels of support by -5% 27,35 and -10% 29.911. As we can se on the Week chart like a double touch in this levels. Idea is so - If to get some stock to buy we can hold by stop levels on to 23.02...
Qualifying Factors: 1.) Support level response. 2.) Target 80% success rate
This is a turning point for this stock, where there are possibilieties for both sides to enter. If there will be agressive buyers or agressive sellers, depends also on overal situation on the market. Personally I´m giving 70% chance for long and 30% for short position. If you have decided to trade it, don´t enter on the entry line, wait for retests (long or short)...
Are you seeing this too. Let's confirm what people are seeing as I need some more thoughts - i am newer to this.
Hello Traders, welcome to today's analysis of Pfizer. -------- Explanation of my video analysis: All the way back in 2012 Pfizer created a massively bullish triangle reversal pattern at the $17.00 level. This was followed by a +200% rally. Since 2022 Pfizer has been dropping significantly and is now retesting the support level which I mentioned in the...
Conservative Trend Trade 1F + long impulse + JOC test level + 1/2 correction + biggest untested volume Sp Calculated affordable stop loss (virtual if it hits the alarm I'll put a limit order to break even and if it doesn't reach it I'll HODL with dividends till original take profit) 1 to 2 R/R take profit with possible extension to 1/2 for monthly...
In an unexpected twist, Pfizer ( NYSE:PFE ), the U.S. pharmaceutical giant, has defied market expectations by reporting a surprise quarterly profit. This surprising turnaround can be attributed to the resilient demand for COVID-related products, outperforming the company's own projections. The earnings report for the fourth quarter revealed adjusted earnings of 10...